FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

4454811000001109: Ciprofloxacin 250mg tablets (Ranbaxy (UK) Ltd) 100 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
26446501000001113 Ciprofloxacin 250mg tablets (Ranbaxy (UK) Ltd) 100 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
48836101000001118 Ciprofloxacin 250mg tablets (Ranbaxy (UK) Ltd) 100 tablet 10 x 10 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ciprofloxacin 250mg tablets (Ranbaxy (UK) Ltd) 100 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Ranbaxy (UK) Ltd) 100 tablet Is a Ciprofloxacin 250mg tablets 100 tablet true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Ranbaxy (UK) Ltd) 100 tablet Is pack of Ciprofloxacin 250mg tablets (Ranbaxy (UK) Ltd) false Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Ranbaxy (UK) Ltd) 100 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Ranbaxy (UK) Ltd) 100 tablet Has active ingredient Ciprofloxacin hydrochloride false Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Ranbaxy (UK) Ltd) 100 tablet Has active ingredient Ciprofloxacin false Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Ranbaxy (UK) Ltd) 100 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Ranbaxy (UK) Ltd) 100 tablet Discontinued indicator Discontinued AMPP(qualifier value) false Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Ranbaxy (UK) Ltd) 100 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Ranbaxy (UK) Ltd) 100 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Ranbaxy (UK) Ltd) 100 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Ranbaxy (UK) Ltd) 100 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Ranbaxy (UK) Ltd) 100 tablet Has AMP Ciprofloxacin 250mg tablets (Ranbaxy (UK) Ltd) true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Ranbaxy (UK) Ltd) 100 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ciprofloxacin true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Ranbaxy (UK) Ltd) 100 tablet Has specific active ingredient Ciprofloxacin hydrochloride true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Ranbaxy (UK) Ltd) 100 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Ranbaxy (UK) Ltd) 100 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Ranbaxy (UK) Ltd) 100 tablet Discontinued indicator Re-marketed true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Ranbaxy (UK) Ltd) 100 tablet Has basis of strength substance Ciprofloxacin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start